ANNX
ANNX
NASDAQ · Biotechnology

Annexon Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$5.11
-0.38 (-6.92%)
As of Mar 22, 10:15 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +698.6% upside
Low Target $23.52
Average Target $40.81
High Target $51.70
Current Price $5.11
Current
$5.11
Target
$40.81
$23.52 $40.81 avg $51.70
Scenario Analysis
Bear Case
$23.52
360.3%
Low target
Base Case
$40.81
+698.6%
Avg target
Bull Case
$51.70
+911.7%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$7.18
-28.8% from high
52-Week Low
$1.29
+297.7% from low
Target vs 52W High
$40.81
+468.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%